Preemptive TIPS for stomach varices bleeding in cirrhosis
Part of Digestive system clinical trials.
This trial tests if placing a TIPS early (before another bleed happens) helps people with cirrhosis who have just had a bleed from stomach varices. It aims to prevent rebleeding and improve outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have cirrhosis (a scarred liver).
- You are in the hospital right now because of bleeding from stomach varices (IGV1 or GOV2 type).
- You have not had TIPS or a surgical shunt in the past.
- You are not pregnant or breastfeeding.
- You are willing to sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether placing a small tube (TIPS) at the time of variceal bleeding can prevent future bleeding in people with cirrhosis and a large clot in the liver's main vein. It aims to see if early TIPS treatment is better than standard care.
This study tests whether placing a small tube (called a TIPS) early in the liver can help people with cirrhosis who have their first episode of moderate to severe belly fluid buildup. The goal is to see if this early procedure improves outcomes compared to standard care.
This trial compares patients who have a rare liver condition (porto-sinusoidal vascular disease) with those who have cirrhosis, to see how a procedure called TIPS (a shunt placed in the liver to reduce blood pressure) works for complications like bleeding, fluid buildup, or blood clots.
This trial compares two approaches to prevent future bleeding from enlarged veins in the esophagus (food pipe) in patients with liver cirrhosis who have already had one bleeding episode. You'll receive either an endoscopic procedure with medication or a minimally invasive vein procedure, to see which works better long-term.
This trial tests a special stent to treat high blood pressure in the liver caused by cirrhosis. It may help patients who need a procedure called TIPS to improve blood flow.
This trial tests a new type of stent placed inside the liver to lower high blood pressure in the portal vein (a major vein that carries blood to the liver). It is aimed at people with cirrhosis who have serious complications like bleeding in the esophagus or stomach, or fluid buildup in the belly that does not go away. The study will see how safe and effective this stent is.
Hear when a new Portal Hypertension trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.